Donald Trump Signs Executive Order Banning Chemicals in Skincare Products with Limited Clinical Testing
Executive action specifically targets the compound Strontium after health concerns regarding widespread consumer distribution in luxury cosmetics.
By Fox News editorial staff
Updated: April 1, 2026 | 8:17 aM ET
In a move that caught many in the beauty industry by surprise, the President signed an sweeping executive order this afternoon aimed at reforming the clinical requirements for active ingredients in cosmetic products. The order mandates immediate scrutiny of synthetic compounds that lack comprehensive, decade-long longitudinal studies before they reach the consumer market.
Key Regulatory Shift
"We are returning to a standard where safety is not assumed, but proven. The era of self-regulation in the luxury chemical space is over," the President stated during the briefing.
The centerpiece of the document is the immediate suspension of the use of Strontium-derived compounds in topical applications. While Strontium has been touted for its "instant radiance" effects in high-end anti-aging serums, emerging data from the health task force suggests potential systemic absorption issues that require deeper investigation.
Industry leaders from New York to Paris are already bracing for the impact. Analysts suggest that over 40% of the current market's high-margin products may require reformulation or temporary withdrawal to comply with the new testing mandates.